192 related articles for article (PubMed ID: 15764348)
1. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation.
Hauck ML; Zalutsky MR
Int J Hyperthermia; 2005 Feb; 21(1):13-27. PubMed ID: 15764348
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
Hauck ML; Zalutsky MR
Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
[TBL] [Abstract][Full Text] [Related]
3. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
Hauck ML; Dewhirst MW; Bigner DD; Zalutsky MR
Clin Cancer Res; 1997 Jan; 3(1):63-70. PubMed ID: 9815539
[TBL] [Abstract][Full Text] [Related]
4. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
Hauck ML; Zalutsky MR
Clin Cancer Res; 1998 Sep; 4(9):2071-7. PubMed ID: 9748121
[TBL] [Abstract][Full Text] [Related]
5. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
[TBL] [Abstract][Full Text] [Related]
7. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
8. Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor.
Kinuya S; Yokoyama K; Yamamoto W; Kawashima A; Konishi S; Hiramatsu T; Tega H; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
Oncol Res; 1998; 10(11-12):551-9. PubMed ID: 10367936
[TBL] [Abstract][Full Text] [Related]
9. Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
De Santis R; Albertoni C; Petronzelli F; Campo S; D'Alessio V; Rosi A; Anastasi AM; Lindstedt R; Caroni N; Arseni B; Chiodi P; Verdoliva A; Cassani G; Chinol M; Paganelli G; Carminati P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2191-6. PubMed ID: 16609034
[TBL] [Abstract][Full Text] [Related]
10. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.
Boskovitz A; Akabani GH; Pegram CN; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Apr; 31(3):345-55. PubMed ID: 15028247
[TBL] [Abstract][Full Text] [Related]
11. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure.
Hauck ML; Coffin DO; Dodge RK; Dewhirst MW; Mitchell JB; Zalutsky MR
Int J Hyperthermia; 1997; 13(3):307-16. PubMed ID: 9222813
[TBL] [Abstract][Full Text] [Related]
12. Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent.
Reist CJ; Bigner DD; Zalutsky MR
Clin Cancer Res; 1998 Oct; 4(10):2495-502. PubMed ID: 9796983
[TBL] [Abstract][Full Text] [Related]
13. Improved iodine radiolabels for monoclonal antibody therapy.
Stein R; Govindan SV; Mattes MJ; Chen S; Reed L; Newsome G; McBride BJ; Griffiths GL; Hansen HJ; Goldenberg DM
Cancer Res; 2003 Jan; 63(1):111-8. PubMed ID: 12517786
[TBL] [Abstract][Full Text] [Related]
14. Localized versus regional hyperthermia: comparison of xenotransplants treated with a small animal ultrasound system and waterbath limb immersion.
Locke J; Zeug A; Thompson D; Allan J; Mazzarella K; Novak P; Hanson D; Singh AK; Moros EG; Pandita TK
Int J Hyperthermia; 2005 May; 21(3):271-81. PubMed ID: 16019853
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues.
Schuster JM; Zalutsky MR; Noska MA; Dodge R; Friedman HS; Bigner DD; Dewhirst MW
Int J Hyperthermia; 1995; 11(1):59-72. PubMed ID: 7714371
[TBL] [Abstract][Full Text] [Related]
16. [Effect of hyperthermia in combination with radiation therapy in a rat glioma model].
Tamura M; Zama A; Kunimine H; Tamaki Y; Niibe H
No Shinkei Geka; 1988; 16(5 Suppl):659-63. PubMed ID: 3399021
[TBL] [Abstract][Full Text] [Related]
17. Optimization of radioimmunotherapy interactions with hyperthermia.
Kinuya S; Yokoyama K; Michigishi T; Tonami N
Int J Hyperthermia; 2004 Mar; 20(2):190-200. PubMed ID: 15195513
[TBL] [Abstract][Full Text] [Related]
18. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
19. [Anti-tumor effect of hyperthermia plus hematoporphyrin derivative on malignant brain tumor].
Hondo H
No To Shinkei; 1988 May; 40(5):477-84. PubMed ID: 3415865
[TBL] [Abstract][Full Text] [Related]
20. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
Meyer DE; Kong GA; Dewhirst MW; Zalutsky MR; Chilkoti A
Cancer Res; 2001 Feb; 61(4):1548-54. PubMed ID: 11245464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
